-
November 10, 2020
How to Learn About Cancer in a Classroom: Shaping Compassionate Doctors
With:The patients and caregivers we serve here at Cancer Commons rely on their doctors to provide expert, compassionate care. Building the skills to give such care can begin early in a doctor’s education. Here, for a change of pace, our… Read more »
-
September 9, 2020
Is Cancer the Best Way to Die?
With:In 2014, the prestigious medical research journal The BMJ published a controversial piece called “Dying of cancer is the best death.” Here, our Curious Dr. George asks the author of that piece, Richard Smith, CBE, FMedSci, if and how his thoughts… Read more »
-
August 21, 2020
The Power of Precision Medicine is Exemplified by Tempus
With:Tempus—a tech company & partner of Cancer Commons—empowers doctors to make data-driven decisions for their patients in real time. Learn how.
-
August 15, 2020
A Case of Male Breast Cancer Patient with CHEK2*1100delC MutationBookmark
George Lundberg, MDResearch paper from Cureus curated by Editor in Chief George Lundberg, MD, who notes:
Breast cancer in men is unusual but important. This academic paper outlines the case of a specific patient who was found to have a genetic mutation that could explain why he was diagnosed at a relatively younger age.
Go to full paper published in Cureus.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
August 14, 2020
Exploiting Cancer’s Tactics to Make Cancer a Manageable Chronic DiseaseBookmark
George Lundberg, MDResearch paper from Cancers curated by Editor in Chief George Lundberg, MD, who notes:
Instead of focusing on “curing” cancer, the authors of this academic research paper focus on approaches to managing cancer as a chronic disease.
Go to full paper published in Cancers.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
June 29, 2020
Cancer Screening Programs Influence Incidence and Causes of Cancer DeathsBookmark
Lola Rahib, PhDArticle from ASCO Daily News curated by Director of Scientific and Clinical Affairs, Lola Rahib, PhD.
In collaboration with MD Anderson Cancer Center and the Pancreatic Cancer Action Network, Cancer Commons presented new research at the American Society of Clinical Oncology (ASCO)’s virtual 2020 meeting. The findings show that, by 2040, we will likely see notable changes in which cancer types are most common and which are most deadly, highlighting the influence of cancer screening programs. This research was led by Dr. Rahib at Cancer Commons.
Go to full article published by ASCO Daily News.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
May 30, 2020
What Have I Learned in More Than Half a Century in Cancer Medicine?Bookmark
George Lundberg, MDArticle from The ASCO Post curated by Editor in Chief George Lundberg, MD, who notes:
“Patients with cancer need to be embraced with love and compassion. They need caring beyond medicine.”Go to full article published by The ASCO Post.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
April 27, 2020
The Challenges of Using Artificial Intelligence to Improve Cancer Treatment
With: Razelle Kurzrock, MDJeff Shrager, PhDIn a previous post, CureMatch co-founder Razelle Kurzrock, MD, told us all about her company’s artificial intelligence (AI) platform that matches patients with treatments based on their cancer’s molecular profile. Here, AI expert Jeff Shrager, PhD, responds, and Kurzrock offers… Read more »
-
March 2, 2020
Using Artificial Intelligence to Match Combination Targeted Therapies in Oncology
With: Razelle Kurzrock, MDA Q&A with Razelle Kurzrock, MD, Director of the Center for Personalized Cancer Therapy and the Rare Tumor Clinic at U.C. San Diego, and Co-Founder and Board Member of CureMatch, Inc. Email: razelle@curematch.com Q: The new understanding of many cancers… Read more »
-
February 22, 2020
‘Fail First’ No More: Pennsylvania Moves to Expand Coverage of Treatments for Advanced CancersBookmark
George Lundberg, MDArticle from The Philadelphia Inquirer curated by Editor in Chief George Lundberg, MD, who notes:
A new Pennsylvania law requires insurance coverage for use of FDA-approved best drugs first, rather than only after failing with a cheaper alternative.
Go to full article published by The Philadelphia Inquirer.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
The Big Picture
Learn more about what’s new in advanced cancer research and treatment, including screening and statistics, using artificial intelligence to improve treatment, and other new horizons in cancer care.
Cancer Commons’ scientists and doctors were very helpful in identifying possible clinical trials for our son’s rare brain tumor.
Joan
Mother of brain tumor patient
Precision oncology is very complicated and changes every day. The scientists of Cancer Commons provide rapid, compassionate, scientifically sound information about best options, a remarkable free service.
Razelle Kurzrock, MD
U.C. San Diego, CureMatch, Inc.